Paul J. Chang to Combined Modality Therapy
This is a "connection" page, showing publications Paul J. Chang has written about Combined Modality Therapy.
Connection Strength
0.030
-
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol. 2018 06 01; 36(16):1611-1618.
Score: 0.030